A look at Ansell’s share price
The Ansell share price hit a record high yesterday at $43.23, trading above the 52-week low of $33.23 on 8 December 2020.
Shares in the global player for health and safety protection solutions have climbed 22.67% year-to-date, outpacing the S&P/ASX 200 Index (ASX: XJO)’s 11% at the time of writing.
The company’s shares have also posted another 4.04% over the last 1 month, at the time of writing. Today’s trading volume is more than 50% of the 20-day average.
The Ansell share price has also gained a further 2.6% over the past 5 days to hit $43.16 at the time of writing, giving the company a market capitalisation of $5.39 billion.
On 8 June 2021, the company announced the appointment of new Chief Executive Officer Neil Salmon, to succeed outgoing CEO Magnus Nicolin, effective September 2021.
In the announcement, Ansell chair John Bevan stated:
Neil has the right combination of financial and operational experience and capability for the CEO role at Ansell. He has worked alongside Magnus for many years and was a key contributor to the strategies which transformed Ansell during that time. More recently, Neil also led our Industrial GBU with its over 7,500 strong manufacturing, marketing and product development workforce located in multiple jurisdictions. His leadership was critical in the management of the initial challenges of the pandemic, positioning the business where it could maximise benefits from the recovery as it emerged.
Investors continue to reward Ansell shares, with the company’s share price gaining 10.5% since this event at the time of writing.
Healius share price snapshot
The Healius share price set a new 52-week high of $4.65 in today’s session, capping off a year-to-date gain of 20.16% at the time of writing.
Trading volume is more than triple of the 20 day average for this time of day. The 52-week range for Healius share price is $2.98–$4.65.
The Australian healthcare company specialises in pathology, imaging and medical facilities. Its shares have gained 9.64% over the previous month and 4.9% in the previous 5 days, giving the company a market capitalisation of $2.8 billion.
Healius has seen its share price increase by 15.86% since May, where it presented a positive trading performance to the Macquarie Australia trading conference.
These 2 ASX shares have each set new 52-week highs after gaining more than 20% each this year, and have both outpaced the ASX 200’s return this year to date.